Celsius (CELH) 10-Q 7 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 06, 2019
Document And Entity Information
Entity Registrant Name	Celsius Holdings, Inc.
Entity Central Index Key	0001341766
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Title of 12(b) Security	Common Stock, $.001 par value
Trading Symbol	CELH
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity File Number	001-34611
Entity Incorporation, State or Country Code	NV
Entity Reporting Status Current	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		68,875,257
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018	[1]
Current assets:
Cash	$ 20,531,891	$ 7,743,181
Accounts receivable-net (note 2)	14,008,998	12,980,396
Note receivable-current (note 6)	1,149,791
Unbilled royalty revenue	252,302
Inventories-net (note 4)	8,786,975	11,482,701
Prepaid expenses and other current assets (note 5)	4,212,180	2,299,375
Total current assets	48,942,137	34,505,653
Cash held in escrow	14,849,999
Note receivable-long term (note 6)	10,348,115
Operating lease-right of use asset (note 7)	153,257
Property and equipment-net (note 8)	128,886	121,854
Total Assets	74,422,394	34,627,507
Current liabilities:
Accounts payable and accrued expenses (note 9)	10,808,603	14,845,211
Other current liabilities (note 10)	117,445	19,933
Operating lease liability-current (note 7)	146,584
Total current liabilities	11,072,632	14,865,144
Long-term liabilities:
Convertible line of credit note payable-related party-net (note 11)		3,500,000
Convertible notes payables -related party-net (note 11)		4,459,381
Operating lease liability-long term (note 7)	12,747
Total Liabilities	11,085,379	22,824,525
Commitments and Contingencies
Stockholders' Equity:
Preferred Stock, $0.001 par value; 2,500,000 shares authorized, zero and zero shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively (note 12)
Common stock, $0.001 par value; 75,000,000 shares authorized, 68,875,257 and 57,002,508 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively (note 14)	68,876	57,003
Additional paid-in capital	126,075,609	85,153,667
Accumulated other comprehensive income/(loss)	(571,120)	(26,997)
Accumulated deficit	(62,236,350)	(73,380,691)
Total Stockholders' Equity	63,337,015	11,802,982
Total Liabilities and Stockholders' Equity	$ 74,422,394	$ 34,627,507
[1]	Derived from Audited Financial Statements

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	2,500,000	2,500,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	75,000,000	75,000,000
Common stock, issued	68,875,257	57,002,508
Common stock, outstanding	68,875,257	57,002,508

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenue (note 3)		$ 20,423,847	$ 16,565,316	$ 51,031,426	$ 37,923,619
Cost of revenue (note 2)		11,801,478	9,694,932	29,821,968	22,307,735
Gross profit		8,622,369	6,870,384	21,209,458	15,615,884
Selling and marketing expenses		4,923,968	8,671,792	14,086,910	18,419,236
General and administrative expenses		2,194,530	2,287,374	7,249,378	7,430,580
Total operating expenses		7,118,498	10,959,166	21,336,288	25,849,816
Income (loss) from operations		1,503,871	(4,088,782)	(126,830)	(10,233,932)
Other Income (Expense):
Interest income		96,300		288,070
Interest on notes		(105,385)		(348,493)
Interest on other obligations		(3,393)	(42,932)	(12,041)	(122,944)
Amortization of discount on notes payable		(528,463)		(707,285)
Gain on Investment repayment-China (Note Receivable Note 6)		(1,888)		12,050,921
Total other income (expense)		(542,829)	(42,932)	11,271,172	(122,944)
Net Income (Loss)		961,042	(4,131,714)	11,144,342	(10,356,876)
Preferred stock dividend			(43,639)		(169,494)
Net income (loss) available to common stockholders		$ 961,042	$ (4,175,353)	$ 11,144,342	$ (10,526,370)
Income (Loss) per share:
Basic (in dollars per share)		$ 0.02	$ (0.08)	$ 0.19	$ (0.21)
Diluted (in dollars per share)		$ 0.03	$ (0.08)	$ 0.20	$ (0.21)
Weighted average shares outstanding:
Basic (in shares)		59,307,404	51,098,575	58,023,685	49,675,624
Diluted (in shares)	[1]	62,532,510	51,098,575	62,050,032	49,675,624
[1]	Please refer to Earnings Per Share section for further details

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss) available to common stockholders, as reported	$ 961,042	$ (4,175,353)	$ 11,144,342	$ (10,526,370)
Other comprehensive (loss) income:
Unrealized foreign currency translation (loss) income	(55,303)	65,949	(71,793)	46,130
Comprehensive income/(loss)	$ 905,739	$ (4,109,404)	$ 11,072,549	$ (10,480,240)

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other-Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Total
Balances at beginning at Dec. 31, 2017	$ 7	$ 45,702	$ 79,101,824	$ (39,378)	$ (61,960,910)	$ 17,147,245
Balances at beginning (in shares) at Dec. 31, 2017	6,760	45,701,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in exchange of preferred stock	$ (4)	$ 4,651	(5,251)			(604)
Issuance of common stock in exchange of preferred stock (in shares)	(4,000)	4,651,163
Stock option expense			770,861			770,861
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 306	(306)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		306,340
Issuance of common stock pursuant to exercise of stock options - Cash		$ 298	142,329			142,627
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		297,773
Preferred stock dividend payable					(82,691)	(82,691)
Foreign currency translation gain (loss)				(53,504)		(53,504)
Net Income (Loss)					(2,876,504)	(2,876,504)
Balances at ending at Mar. 31, 2018	$ 3	$ 50,957	80,009,457	(92,882)	(64,920,105)	15,047,430
Balances at ending (in shares) at Mar. 31, 2018	2,760	50,956,869
Balances at beginning at Dec. 31, 2017	$ 7	$ 45,702	79,101,824	(39,378)	(61,960,910)	17,147,245
Balances at beginning (in shares) at Dec. 31, 2017	6,760	45,701,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock dividend payable						(169,494)
Net Income (Loss)						(10,356,876)
Balances at ending at Sep. 30, 2018	$ 3	$ 51,125	82,659,486	6,752	(71,704,224)	11,013,142
Balances at ending (in shares) at Sep. 30, 2018	2,760	51,124,946
Balances at beginning at Mar. 31, 2018	$ 3	$ 50,957	80,009,457	(92,882)	(64,920,105)	15,047,430
Balances at beginning (in shares) at Mar. 31, 2018	2,760	50,956,869
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			1,179,764			1,179,764
Issuance of common stock pursuant to exercise of stock options - Cash		$ 106	37,575			37,681
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		106,282
Preferred stock dividend payable					(43,164)	(43,164)
Foreign currency translation gain (loss)				33,685		33,685
Net Income (Loss)					(3,348,658)	(3,348,658)
Balances at ending at Jun. 30, 2018	$ 3	$ 51,063	81,226,796	(59,197)	(68,311,927)	12,906,738
Balances at ending (in shares) at Jun. 30, 2018	2,760	51,063,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			1,153,152			1,153,152
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 2	(2)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		1,795
Preferred stock dividend payable					(43,639)	(43,639)
Foreign currency translation gain (loss)				65,949		65,949
Issuance of common stock in exchange of service		$ 60	279,540			279,600
Issuance of common stock in exchange of service (in shares)		60,000
Net Income (Loss)					(3,348,658)	(4,131,714)
Balances at ending at Sep. 30, 2018	$ 3	$ 51,125	82,659,486	6,752	(71,704,224)	11,013,142
Balances at ending (in shares) at Sep. 30, 2018	2,760	51,124,946
Balances at beginning at Dec. 31, 2018		$ 57,003	85,153,667	(26,997)	(73,380,691)	11,802,982	[1]
Balances at beginning (in shares) at Dec. 31, 2018		57,002,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			1,358,503			1,358,503
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 115	(115)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		115,107
Issuance of common stock pursuant to exercise of stock options - Cash		$ 80	24,680			24,760
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		80,750
Beneficial Conversion Feature on Convertible Instruments			166,667			166,667
Foreign currency translation gain (loss)				260,665		260,665
Net Income (Loss)					11,656,594	11,656,594
Balances at ending at Mar. 31, 2019		$ 57,198	86,703,402	233,668	(61,724,097)	25,270,171
Balances at ending (in shares) at Mar. 31, 2019		57,198,365
Balances at beginning at Dec. 31, 2018		$ 57,003	85,153,667	(26,997)	(73,380,691)	11,802,982	[1]
Balances at beginning (in shares) at Dec. 31, 2018		57,002,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)						11,144,342
Balances at ending at Sep. 30, 2019		$ 68,876	126,075,609	(571,120)	(62,236,350)	63,337,015
Balances at ending (in shares) at Sep. 30, 2019		68,875,257
Balances at beginning at Mar. 31, 2019		$ 57,198	86,703,402	233,668	(61,724,097)	25,270,171
Balances at beginning (in shares) at Mar. 31, 2019		57,198,365
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			1,095,792			1,095,792
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 80	(80)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		79,488
Issuance of common stock pursuant to exercise of stock options - Cash		$ 93	122,574			122,667
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		93,334
Foreign currency translation gain (loss)				(256,974)		(256,974)
Net Income (Loss)					(1,473,295)	(1,473,295)
Balances at ending at Jun. 30, 2019		$ 57,371	87,921,688	(23,306)	(63,197,392)	24,758,361
Balances at ending (in shares) at Jun. 30, 2019		57,371,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			900,000			900,000
Issuance of common stock-Capital Raise		$ 7,986	26,947,451			26,955,437
Issuance of common stock-Capital Raise (in shares)		7,986,110
Issuance of common stock-Notes Payable Conversion		$ 3,197	10,230,136			10,233,333
Issuance of common stock-Notes Payable Conversion (in shares)		3,196,460
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 250	(250)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		250,000
Issuance of common stock pursuant to exercise of stock options - Cash		$ 72	76,584			76,656
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		71,500
Foreign currency translation gain (loss)				(547,814)		(547,814)
Net Income (Loss)					961,042	961,042
Balances at ending at Sep. 30, 2019		$ 68,876	$ 126,075,609	$ (571,120)	$ (62,236,350)	$ 63,337,015
Balances at ending (in shares) at Sep. 30, 2019		68,875,257
[1]	Derived from Audited Financial Statements

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net Income (loss)	$ 11,144,342	$ (10,356,876)
Adjustments to reconcile net income/(loss) to net cash used in operating activities:
Depreciation and amortization	761,649	34,620
Shares issued for settlement of legal claim		279,600
Stock-based compensation expense	3,354,295	3,103,778
Allowance for bad debt	62,678	(9,632)
Inventory allowance for excess and obsolete products	300,143
Gain on Investment repayment from China (Note Receivable Note 6)	(12,050,921)
Changes in operating assets and liabilities:
Accounts receivable-gross	(4,405,426)	(6,451,701)
Inventories	2,136,895	(1,543,250)
Prepaid expenses and other current assets	(2,087,991)	(2,156,230)
Accounts payable and accrued expenses	(27,338)	8,189,325
Accrued preferred dividends		(91,111)
Unbilled royalty revenue	(252,302)
Other current assets/liabilities	97,512	(3,387)
Net cash used in operating activities	(966,464)	(9,004,864)
Cash flows from investing activities:
Purchase of property and equipment	(55,321)	(93,482)
Cash paid to escrow for acquisition	(14,849,999)
Net cash (used in) investing activities	(14,905,320)	(93,482)
Cash flows from financing activities:
Proceeds from notes payable related party-net	1,500,000
Proceeds from exercise of stock options	224,083	179,704
Net proceeds from sale of common stock	26,955,437
Net cash provided by financing activities	28,679,520	179,704
Effect of exchange rate changes on cash and cash equivalents	(19,026)	46,130
Net increase (decrease) in cash	12,788,710	(8,872,512)
Cash at beginning of the period	7,743,181	14,186,624
Cash at end of the period	20,531,891	5,314,112
Cash paid during period for:
Interest	131,528	132,425
Non-cash investing and financing activities:
Accrued preferred dividends		129,493
Debt Conversion and Related Accrued Expenses	10,233,333
Non-Cash Items Related to China Settlement:
Accounts Receivable	3,314,146
Inventory	258,688
Pre-paid expense and other current assets	175,185
Accounts payable and accrued expenses	$ (3,748,019)

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	1. ORGANIZATION AND DESCRIPTION OF BUSINESS Business Company Celsius Holdings The Company is engaged in the development, marketing, sale and distribution of “ functional

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation – US GAAP Significant Estimates Segment Reporting Disclosed About Segments of an Enterprise and Related Information.) Our chief operating decision-maker is considered to be our Chief Executive Officer (CEO). The CEO reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying consolidated statement of operations. Therefore, the Company has determined that it operates in a single operating segment. For the nine months ended September 30, 2019 and 2018 all material assets and revenues of the Company were in the United States except as disclosed in Note 3. Concentrations of Risk The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At September 30, 2019, the Company had approximately $20.3 million in excess of the Federal Deposit Insurance Corporation limit. For the nine months ended September 30, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 13.9 % 17.6 % B* 12.9 % 7.9 % All other 73.2 % 74.5 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States. Revenues from all other customers were mainly derived in the United States. At September 30, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 32.4 % 39.1 % B* 11.5 % 5.5 % All other 56.1 % 55.4 % Total 100.0 % 100.0 % * Receivables from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States. Cash Equivalents Accounts Receivable Inventories Property and Equipment Impairment of Long-Lived Assets Revenue Recognition Revenue is derived from the sale of beverages. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, slotting fees, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue. Customer Advances Advertising Costs Research and Development Foreign Currency Translation-Chinese Yuan Renminbi — As of and for the nine months ended September 30, 2019 and September 30, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: September 30, September 30, Exchange rate on balance sheet dates USD: CNY exchange rate 7.15 6.87 Average exchange rate for the period 7.12 6.85 USD: CNY exchange rate Fair Value of Financial Instruments Fair Value Measurements Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. Other than these noted previously, the Company did not have any other assets or liabilities measured at fair value at September 30, 2019 and December 31, 2018. Income Taxes — Accounting for Uncertain Income Tax Positions. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25 Definition of Settlement, Earnings per Share The effects of dilutive instruments have been presented for the year-to-date net income as of September 30, 2019. Other periods presented do not reflect the dilutive shares, as the effects would be anti-dilutive due to the fact that losses are being reflected for those periods. Please refer to the below table for additional details: For the three months For the nine months 2019 2018 2019 2018 Net income (loss) available to common stockholders $ 961,042 $ (4,131,714 ) $ 11,144,342 $ (10,356,876 ) Adjustments for diluted earnings: Preferred Stock Dividend (43,639 ) (169,494 ) Interest expense on convertible notes 105,385 - 348,493 - Amortization of discount on notes payable 528,464 - 707,286 - Diluted net income (loss) available to common stockholders $ 1,594,891 $ (4,175,353 ) $ 12,200,121 $ (10,526,370 ) Income (Loss) per share: Basic $ 0.02 $ (0.08 ) $ 0.19 $ (0.21 ) Diluted $ 0.03 $ (0.08 ) $ 0.20 $ (0.21 ) Weighted average shares outstanding: Basic 59,307,404 51,098,575 58,023,685 49,675,624 Diluted 62,532,510 51,098,575 62,050,032 49,675,624 Share-Based Payments Cost of Sales Operating Expenses Shipping and Handling Costs Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. In June 2016, the FASB issued ASU No. 2016-13 & updated in Nov 2018 ASU 2018-19, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. ASU 2016-13 is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2019. Early adoption is permitted after fiscal years beginning December 15, 2018. The Company is currently evaluating the potential impact of adopting this guidance on our financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820. The ASU is effective for the Registrants for fiscal years beginning after December 15, 2019, and interim periods therein. Early adoption is permitted. The Company is currently assessing the impact of this standard on our consolidated financial statements. All new accounting pronouncements issued but not yet effective are not expected to have a material impact on our results of operations, cash flows or financial position with the exception of the updated previously disclosed above, there have been no new accounting pronouncements not yet effective that have significance to our consolidated financial statements. Liquidity In addition to cash flow from operations, our primary sources of working capital have been private placements of our securities and our credit facilities with CD Financial, LLC (“CD Financial”), an affiliate of a principal shareholder of the Company, as well as Charmnew Limited and Grieg International Limited. Charmnew Limited is an existing shareholder of record affiliated with Li Ka Shing, one of our principal shareholders. Grieg International Limited is an existing shareholder of record affiliated with Chau Hoi Shuen Solina, one of our principal shareholders. If our sales volumes do not meet our projections, expenses exceed our expectations, our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing.

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
REVENUE	3. REVENUE The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Sales taxes and other similar taxes are excluded from revenue. Information about the Company’s net sales by geographical location for the nine months ended September 30, 2019 and 2018 are as follows: For the nine months ended September 30, September 30, 2019 2018 North America $ 42,607,433 $ 27,911,538 Europe 7,635,845 7,097,942 Asia 629,028 2,740,175 Other 159,120 173,964 Net sales $ 51,031,426 $ 37,923,619 License Agreement In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement. Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation. The Company recognizes revenue from the agreement over time because the customer simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because its efforts in providing the exclusive license rights and ongoing support occur on a generally even basis throughout the year. Total revenue recognized under the agreement was approximately $263,273 for the nine months ended September 30, 2019 and is reflected in the Company’s Asia reporting segment which was determined by the minimum royalties due during first year, as per the licensing agreement.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
INVENTORIES	4. INVENTORIES Inventories consist of the following at: September 30, December 31, 2019 2018 Finished goods $ 6,761,898 $ 8,739,877 Raw Materials 2,399,872 2,817,476 Less: Inventory allowance for excess & obsolete products (374,795 ) (74,652 ) Inventories $ 8,786,975 $ 11,482,701

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	9 Months Ended
	Sep. 30, 2019
Prepaid Expense and Other Assets, Current [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS	5. PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets total $4.2 million and $2.3 million at September 30, 2019 and December 31, 2018, respectively. The $4.2 million and the $2.3 million at December 31, 2018, of pre-paid expenses consists mainly of prepaid advertising, prepaid insurance, prepaid slotting fees and net deposits on purchases.

NOTE RECEIVABLE

NOTE RECEIVABLE	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
NOTE RECEIVABLE	6. NOTE RECEIVABLE Note receivable consists of the following at: September 30, December 31, 2019 2018 Note Receivable-current $ 1,149,791 $ - Note Receivable-non-current 10,348,115 - Total Note Receivable $ 11,497,906 $ - On January 1, 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng will repay the market investment Celsius has made into China to date, over a five-year period, under an unsecured, interest-bearing note receivable (“Note”). The initial outstanding principal under the Note was approximately $12.2 million which is denominated in Chinese Renminbi (CNY) and was recorded as Other Income on the Consolidated Statements of Operations. The amount recognized considered the net of the balances of the accounts receivable, accounts payable and accrued expenses, as well as the marketing investments that were performed in the China market. Scheduled principal payments plus accrued interest are due annually on March 31 of each year starting in 2020. The Note is recorded at amortized cost basis and accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. For the nine months ended September 30, 2019, the weighted average interest rate was 3.21% and interest income was $288,070. The Company assesses the Note for impairment periodically by evaluating whether it is probable that the Company will be unable to collect all the contractual interest and principal payments as scheduled in the Note agreement, based on historical experience about Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At September 30, 2019, the Note was not deemed to be impaired.

LEASES

LEASES	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
LEASES	7. LEASES In February 2016, the FASB issued Accounting Standards Update 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires lessees to recognize a right-of-use (ROU) asset and lease liability in the balance sheet for all leases, including operating leases with terms of more than twelve months. The Company adopted ASU No. 2016-02, as amended, effective January 1, 2019. We recognized a ROU asset and a corresponding lease liability measured based on the present value of the future minimum lease payments utilizing our incremental borrowing rate as the basis for our computations. As of January 1, 2019, we recognized right to use assets in the amount of $259,358 and a corresponding liability. The asset is being amortized over the life of the lease agreement. As of September 30, 2019, the value of the asset amounted to $153,257. The adoption of the guidance did not have a material impact on our Statement of Operations or Statement of Cash flows. The ROU represents our right to utilize the corresponding asset for the lease term and the related lease liability translates into an obligation related to the lease payments. The operating lease liability as of September 30, 2019 amounted to $159,332 of which the short-term value amounted to $146,586 and the long-term portion was $12,747. Company entered into an office lease with a related party effective October 2015. The monthly rent amounts to $12,452 per month until October 2019 and then increases to $12,826 per month until the termination of the lease in October 2020. As of September 30, 2019, the remaining lease term is 13 months and the discount rate is 5%. Future annual minimum cash payments required under this operating type lease as of September 30, 2019 are as follows: Future Minimum Lease Payments 2019 $ 38,103 2020 128,259 Total Minimum Lease Payments $ 166,362 Less: Amount representing interest (7,031 ) Present value of lease liabilities $ 159,331 Less Current Portion 146,584 Long-Term Portion 12,747

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	8. PROPERTY AND EQUIPMENT Property and equipment consist of the following at: September 30, December 31, 2019 2018 Furniture and equipment $ 505,570 $ 451,576 Less: accumulated depreciation (376,684 ) (329,722 ) Total $ 128,886 $ 121,854 Depreciation expense amounted to $48,289 and $34,644 during the nine months ended September 30, 2019 and 2018, respectively.

ACCOUNTS PAYABLE AND ACCRUED EX

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following at: September 30, December 31, 2019 2018 Accounts payable $ 5,119,452 $ 5,825,446 Accrued expenses 5,689,151 9,019,765 Total $ 10,808,603 $ 14,845,211

OTHER LIABILITIES

OTHER LIABILITIES	9 Months Ended
	Sep. 30, 2019
Accrued Liabilities and Other Liabilities [Abstract]
OTHER LIABILITIES	10. OTHER LIABILITIES Other current liabilities consist of the following at: September 30, December 31, 2019 2018 Other Liabilities-State Beverage Container Deposit $ 117,445 $ 19,933 Total $ 117,445 $ 19,933

NOTES PAYABLE - RELATED PARTY

NOTES PAYABLE - RELATED PARTY	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
NOTES PAYABLE - RELATED PARTIES	11. NOTES PAYABLE - RELATED PARTIES Line of credit convertible note payable - related parties consists of the following as of: September 30, December 31, 2019 2018 Note Payable – line of credit In July 2010, the Company entered into a line of credit note payable with a related party and major shareholder which carries interest of five percent per annum paid quarterly. The Company can borrow up to $9,500,000. The Company has pledged all its assets as security for the line of credit. The note matures in January 2020, at which time the principal amount is due. During April 2015, the Company issued $4,000,000 of convertible series D preferred series in exchange for cancellation of $4,000,000 of this line, reducing the amount to $4,500,000. During March 2018, the Company issued $1,000,000 of common stock in exchange for cancellation of $1,000,000 of this line, reducing the amount to $3,500,000. In December 2018, the Company amended and restated the note payable into a line of credit loan agreement continuing to carry a five percent per annum interest but payable semi-annually. The Company can now borrow up to $5.0 million. As a result, of this substantial modification which was treated as a debt extinguishment, a new liability was established and a loss of $377,048 on the extinguishment of debt was recognized. The note had a maturity date of December 2020. In January 2019, the Company increased the borrowed amount by $1,500,000. In September 16, 2019, the principal value of the note was converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. The principal balance of $5.0 million and the accrued but unpaid interest in the amount of $52,778 were converted into common shares. Consequently, a total of $5,052,778 were converted at the conversion price of $3.39 based on the on the average of the closing price for the shares during the ten (10) business days prior to the last advance date, less a discount of 10%, in accordance with the promissory note. As a result of the conversion of the promissory note, the company recognized the remaining un-amortized balance of the discount of $108,454, as interest expense. Long-term portion-Net of Discount $ - $ 3,500,000 September 30, December 31, 2019 2018 Convertible Note Payable In December 2018, the Company entered into a line of credit note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $3.0 million. This note had an unamortized discount of $205,837 and $324,371 as of September 16, 2019 and as of December 31, 2018, respectively. The unamortized discount of $205,837 was recognized as interest expense upon conversion. The note matured in December 2020. In September 16, 2019, the principal value of the note of $3.0 million and the accrued but unpaid interest in the amount of $108,333 were converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. A total of 3,108,333 were converted at the conversion price of $3.04 which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%, resulting in the issuance of 1,022,568 shares. - 2,675,629 In December 2018, the Company entered into a line of credit convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $2.0 million. This note had an unamortized discount of $137,225 and $216,248 as of September 36, 2019 and as of December 31, 2018, respectively. The unamortized discount of $137,225 was recognized as interest expense upon conversion. The note matured in December 2020. In September 16, 2019, the principal value of the note of $2.0 million and the accrued but unpaid interest in the amount of $72,222 were converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. A total of 2,072,222 were converted at the conversion price of $3.04 which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%, resulting in the issuance of 681,712 shares. - 1,783,752 Long-term portion-Net of Discount $ - $ 4,459,381

PREFERRED STOCK - RELATED PARTY

PREFERRED STOCK - RELATED PARTY	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
PREFERRED STOCK - RELATED PARTY	12. PREFERRED STOCK – RELATED PARTY The Company entered into a securities purchase agreement with CDS Ventures of South Florida, LLC (“CDS”) and CD Financial, LLC (“CD”). CDS and CD are limited liability companies which are affiliates of the Company’s principal shareholder. The Company issued 2,200 shares of its Series C Preferred Stock (the “Preferred C Shares”) in exchange for the conversion of a $550,000 short term loan from CDS and the conversion of $1,650,000 in indebtedness under the Company’s line of credit with CD (the “CD Line of Credit”). The Preferred C Shares are convertible into our common stock at the option of the holder thereof at a conversion price of $0.52 per share at any time until December 31, 2018, at which time they will automatically convert into shares of our common stock determined by dividing the liquidation preference of $1,000 per Preferred C Share by the conversion price then in effect. The conversion price is subject to adjustment in the event of stock dividends, stock splits and similar events. The Preferred C Shares accrue cumulative annual dividends at the rate of 6% per annum, payable by the issuance of additional Preferred C Shares. The holder of Preferred C Shares votes on an “as converted” basis, together with holders of common stock as a single class on all matters presented to shareholders for a vote, except as required by law. In April 2015, the Company issued 180 Preferred C Shares valued at $180,000 in settlement of $180,000 in accrued preferred C dividends. In October 2017, the Company issued 383 Preferred C Shares valued at $383,000 in settlement of $383,000 in accrued preferred C dividends. As of December 31, 2018, $255,903 of dividends have been accrued and converted into 256 of additional Preferred C. The Preferred C Shares matured on December 31, 2018 and were exchanged for 5,806,022 shares of Company common stock. On April 16, 2015, the Company entered into an amendment to its existing Loan and Security Agreement (the “Amendment”) with CD an affiliate of CDS Ventures and Mr. DeSantis. Pursuant to the Amendment, the outstanding principal amount of the CD note payable was reduced by $4.0 million, which amount was converted into 4,000 shares of a newly-designated Series D Preferred Stock (the “Preferred D Shares”). This related party was given a conversion price of $0.86 per common share, whereas other investors purchased common shares at $0.89 in the private placement, as discussed in note 12. The difference of $0.03 per share, which resulted in $139,535, was recorded as a dividend in accordance with ASC 470-20-35, subsequent measurement for debt with conversion and other options. The Preferred D Shares are convertible into our common stock at the option of the holder thereof at a conversion price of $0.86 per share until the earlier of the January 2, 2021 due date of our note payable with CD Financial or such earlier date as the note payable is satisfied (the “Maturity Date”). The conversion price is subject to adjustment in the event of stock dividends, stock splits and similar events. The Preferred D Shares accrue cumulative annual cash dividends at the rate of 5% per annum, payable quarterly in cash and have a liquidation preference of $1,000 per share. On the Maturity Date, the Preferred D Shares automatically convert into shares of our common stock in a number determined by dividing the $1,000 per Preferred D Share liquidation preference plus any accrued but unpaid dividends, by the conversion price then in effect. The Holder shall have the right, at its election, to require the Company to redeem all or any portion of the shares held by the holder in exchange for cash or common stock upon the occurrence of certain events which management believes are under the control of the Company. As of September 30, 2018, none of the contingent events have occurred and in accordance with ASC-480-10-25 “Distinguishing Liabilities from Equity” and Regulation S-X-Rule 5-02-27, the Company has classified these shares as permanent equity. The Preferred D Shares may also be redeemed by us at any time on or after December 31, 2017, at a redemption price equal to 104% of the liquidation preference. The holder of the Preferred D Shares votes on an “as converted” basis, together with holders of common stock as a single class on all matters presented to shareholders for a vote, except as required by law. In March 2018, the Preferred D shares were converted into 4,651,163 shares of common stock.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	13. RELATED PARTY TRANSACTIONS The Company’s office is rented from a company affiliated with CD Financial, LLC which is controlled by one of our major shareholders. Currently, the lease expires on October 2020 with monthly rent of $12,452. The rental fee is commensurate with other properties available in the market. Other related party transactions are discussed in Notes 11 and 12.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
STOCKHOLDERS' EQUITY	14. STOCKHOLDERS’ EQUITY Issuance of common stock pursuant to services performed On July 19, 2018 the Company settled a legal matter that was filed in Superior Court of the State of California, Los Angeles County, by Statewide Beverage Company, Inc. (“Statewide”), a former distributor of the Company’s products. As part of the settlement the Company issued 60,000 shares of “restricted” stock, to the ten plaintiffs involved in the complaint for a total fair value of $279,600, or $4.66 per share, representing the closing stock price on the settlement date. The stock “restriction” pertains to the shareholders intention of using the shares for investment purposes only and not with a view to distribute or resell the shares or any part thereof or interest therein. However, the Stockholder’s rights allow for the selling or otherwise disposal of all or part of the shares pursuant to an exemption under the Securities Act of 1933, as amended (the Securities Act”) and applicable state securities laws or pursuant to registration of the share under such laws. Issuance of common stock pursuant to exercise of stock options During the nine months ended September 30, 2019, the Company issued an aggregate of 690,179 shares of its common stock pursuant to the exercise of stock options granted under the Company’s 2015 Stock Incentive Plan. The Company received aggregate proceeds of $224,083 for 245,584 options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. During the nine months ended September 30, 2018, the Company issued an aggregate of 712,190 shares of its common stock pursuant to the exercise of stock options granted under the Company’s 2006 & 2015 Stock Incentive Plan. The Company received aggregate proceeds of $180,308 for options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. Issuance of preferred stock pursuant to private placement In March 2018, the 4,000 preferred D shares were converted into 4,651,163 shares of common stock. Refer to Note 12 for discussion on preferred stock issuances. Issuance of common stock pursuant to public placement On September 16, 2019 the Company issued 7,986,110 in a public placement and obtained gross proceeds of $28,749,996 and paid $1,585,000 in commissions & fees and incurred in $209,559 of expenses related to the capital raise thereby resulting in net-proceeds in the amount of $26,955,437. Conversion of Notes Payable into common stock On September 16, 2019, the company had three Notes Payable outstanding with related parties for a total principal value of $10 million. As per the terms of the agreements, the principal values of notes payable and any accrued but unpaid interest are convertible into common stock of the Company. Moreover, also as per the terms of the agreements, in the event of financing greater than $25.0 million, the principal value of the notes and any accrued but unpaid interest are automatically converted into the company’s common stock. As result of the public financing which raised $27,063,779, the principal balance of the notes payable and the accrued but unpaid interest were converted resulting in the issuance of 3,196,460, shares of common stock. The shares were issued at the contractual conversion prices per the loan agreements. Refer to Note 11 for discussion on the conversion of the notes payable.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	15. STOCK-BASED COMPENSATION The Company adopted an Incentive Stock Plan on January 18, 2007. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. While the plan terminates 10 years after the adoption date, issued options have their own schedule of termination. During 2013, the majority of the shareholders approved to increase the total available shares in the plan from 2.5 million to 3.5 million shares of common stock. During May 2014, the majority of the shareholders approved to increase the total available shares in the plan from 3.5 million to 4.25 million shares of common stock, during February 2015, the majority of the shareholders approved to increase the total available shares in the plan from 4.25 million to 4.6 million shares of common stock and during April 2015, the majority of the shareholders approved to increase the total available shares in the plan from 4.6 million to 5.1 million shares of common stock. Upon exercise, shares of new common stock are issued by the Company. The Company adopted the 2015 Stock Incentive Plan on April 30, 2015. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. The 2015 Plan permits the grant of options and shares for up to 5,000,000 shares. In addition, there is a provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2017. As of September 30, 2019, 1,898,195 shares are available. Under the 2015 Stock Option Plan the Company has issued options to purchase approximately 5.33 million shares at an average price of $3.66 per share with a fair value of $2.76 million. For the nine months ended September 30, 2019 and 2018, the Company issued options to purchase 1.68 million and 1.71 million shares. For the nine months ended September 30, 2019 and 2018, the Company recognized an expense of approximately $3,354,295 and $3,103,778 respectively, of non-cash compensation expense (included in General and Administrative expense in the accompanying Consolidated Statement of Operations) determined by application of a Black Scholes option pricing model with the following inputs: exercise price, dividend yields, risk-free interest rate, and expected annual volatility. As of September 30, 2019, the Company had approximately $7,217,396 of unrecognized pre-tax non-cash compensation expense, which the Company expects to recognize, based on a weighted-average period of 3 years. The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. There are options to purchase approximately 2.30 million shares that are vested as of September 30, 2019. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black - Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: Nine months ended September 30, 2019 2018 Expected volatility 58.62%-121.32% 91.19-113.03% Expected term 4.02-5.00 Years 4.7 – 5.06 Years Risk-free interest rate 1.79% - 2.72% 2.56% - 2.86% Forfeiture Rate 0.00% 0.00% The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant. A summary of the status of the Company’s outstanding stock options as of September 30, 2019 and changes during the period ending on that date is as follows: Weighted Aggregate Intrinsic Average Shares Exercise Value Remaining (000’s) Price (000’s) Term (Yrs) Options Balance at December 31, 2018 4,840 $ 3.04 $ 5,338 5.05 Granted 1,675 $ 3.87 Exercised (900 ) $ 0.97 Forfeiture and cancelled (286 ) $ 2.59 Balance at September 30, 2019 5,329 $ 3.66 $ 2,758 6.10 Exercisable at September 30, 2019 2,305 $ 2.76 The following table summarizes information about employee stock options outstanding at September 30, 2019: Outstanding Options Vested Options Number Number Outstanding Exercisable at Weighted Weighted at Weighted Weighted September 30, Average Average September 30, Average Average Range of 2019 Remaining Exercise 2019 Exercise Remaining Exercise Price (000’s) Term Price (000’s) Price Term $0.20 - $0.53 359 3.45 $ 0.27 359 $ 0.27 3.45 $0.65 - $1.80 342 1.60 $ 1.05 342 $ 1.05 1.60 $1.83 - $2.84 554 0.85 $ 2.06 555 $ 2.07 2.85 $3.20 - $6.20 4,074 7.16 $ 4.39 1,049 4.52 5.23 $7.20 - $22.00 0 0 $ 0 0 $ 0 0 Outstanding options 5,329 6.10 $ 3.66 2,305 $ 2.76 3.84 Restricted Stock Awards Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holder of a restricted stock award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a shareholder of the Company, including the right to vote the shares. The value of stock awards that vest over time was established by the market price on the date of its grant. A summary of the Company’s restricted stock activity for the nine months ended September 30, 2019 and 2018 is presented in the following table: For the Nine Months ended September 30, 2019 September 30, 2018 Weighted Weighted Average Average (000’s) Grant Date (000’s) Grant Date Shares Fair Value Shares Fair Value Unvested at beginning of period 38,889 $ 3.64 72,222 $ — Granted — — — — Vested 8,333 3.64 (25,000 ) — Unvested at end of period 30,556 $ 3.64 47,222 $ 3.64 Unrecognized compensation expense related to outstanding restricted stock awards to employees and directors as of September 30, 2019 was $50,709 and is expected to be recognized over a weighted average period of 0.42 years.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	16. COMMITMENTS AND CONTINGENCIES The Company has entered into distribution agreements with liquidated damages in the event the Company cancels the distribution agreements without cause. Cause has been defined in various ways. It is management’s belief that no such agreement has created any liability as of September 30, 2019. On December 18, 2018, Rockstar, Inc. (“Rockstar”) filed suit against Celsius in federal district court in the District of Nevada. Rockstar’s complaint alleges three claims for relief: (a) false advertising in violation of 15 USC §1125(a); (b) violation of the Nevada Deceptive Trade Practice Act; and (c) Nevada common law unfair competition. On January 30, 2019, Celsius filed its answer to the complaint denying the allegations by Rockstar, and setting forth certain affirmative defenses. On October 3, 2019, Celsius filed its motion for judgment on the pleadings or for summary judgment seeking a dismissal of the complaint because a) Rockstar produced no documents and took no discovery and has no facts to support its claims; b) Rockstar lacks a competitive injury sufficient for false advertising standing; c) Celsius’ product claims are subjective and not actionable; and d) Rockstar’s claims are really claims under the Food Drug and Cosmetics Act which have no private right of action. The motion is currently being briefed. Furthermore, discovery is closed and the Court is currently considering whether to permit additional time for discovery. Celsius believes that it has not committed the violations alleged, that it has strong defenses, and it intends to vigorously defend itself against the claims by Rockstar. On April 8, 2019, Daniel Prescod filed suit against Celsius Holdings, Inc., Case No. 19STCV09321, pending in Superior Court for the State of California, County of Los Angeles (the “Prescod Litigation”). Daniel Prescod asserts that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” violates California Consumer Legal Remedies Act, California Business and Professions Code Section 17200, et seq., and California Business and Professions Code Section 17500, et seq., because citric acid acts as a preservative. The Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. The Company intends to contest the claims vigorously. Since this matter is still in its initial stages, the Company is unable to predict the outcome at this time. In addition to the foregoing, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. On September 25, 2019, as per the share purchase agreement that was executed in relation to the acquisition of our Nordics distributor, $14,008,999, were placed in an escrow account regarding the cash consideration to be provided as part of the transaction. The acquisition was finalized on October 25, 2019.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	17. SUBSEQUENT EVENTS Business Acquisition On October 25, 2019, the Company acquired 100 percent of the outstanding common shares of Func Food Group OYJ (“Func Food”) for approximately $24.2 million, which consisted of $14.8 million of cash and $9.4 million of bond issuances (net of bond discount of $476 thousand) to restructure and settle Func Food’s pre-existing debt. Func Food is a marketer and distributor of nutritional supplements, health food products and beverages that support sport activities and healthy living and lifestyles in Finland, Sweden, and Norway. Func Food has been the Nordic distributor of Celsius products since 2015 and, as a result of the acquisition, the Company expects to further increase its Nordic market share by leveraging collaborations, revamping its marketing strategy and focusing on core products. It also expects to reduce costs through economies of scale. The acquisition of Func Food will be accounted for as a business combination using the acquisition method of accounting. The accounts receivable balance as of October 25, 2019 from Fund Food and it’s subsidiaries amounted to $4.6 million, as part of the consolidation process this amount will be treated as an Intercompany balance. As a result of the limited time since the acquisition date and the effort required to conform the financial statements to the Company’s practices and policies, the initial accounting for the business combination is incomplete at the time of this filing. As a result, the Company is unable to provide the amounts recognized as of the acquisition date for the major classes of assets acquired and liabilities assumed and goodwill. Also, the Company is unable to provide pro forma revenues and earnings of the combined entity. This information will be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation – US GAAP
Significant Estimates	Significant Estimates
Segment Reporting	Segment Reporting Disclosed About Segments of an Enterprise and Related Information.) Our chief operating decision-maker is considered to be our Chief Executive Officer (CEO). The CEO reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying consolidated statement of operations. Therefore, the Company has determined that it operates in a single operating segment. For the nine months ended September 30, 2019 and 2018 all material assets and revenues of the Company were in the United States except as disclosed in Note 3.
Concentrations of Risk	Concentrations of Risk The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At September 30, 2019, the Company had approximately $20.3 million in excess of the Federal Deposit Insurance Corporation limit. For the nine months ended September 30, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 13.9 % 17.6 % B* 12.9 % 7.9 % All other 73.2 % 74.5 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States. Revenues from all other customers were mainly derived in the United States. At September 30, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 32.4 % 39.1 % B* 11.5 % 5.5 % All other 56.1 % 55.4 % Total 100.0 % 100.0 % * Receivables from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States.
Cash Equivalents	Cash Equivalents
Accounts Receivable	Accounts Receivable
Inventories	Inventories
Property and Equipment	Property and Equipment
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
Revenue Recognition	Revenue Recognition Revenue is derived from the sale of beverages. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, slotting fees, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue.
Customer AdvanceS	Customer Advances
Advertising Costs	Advertising Costs
Research and Development	Research and Development
Foreign Currency Translation	Foreign Currency Translation-Chinese Yuan Renminbi — As of and for the nine months ended September 30, 2019 and September 30, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: September 30, September 30, Exchange rate on balance sheet dates USD : CNY exchange rate 7.15 6.87 Average exchange rate for the period 7.12 6.85 USD : CNY exchange rate
Fair Value of Financial Instruments	Fair Value of Financial Instruments
Fair Value Measurements	Fair Value Measurements Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. Other than these noted previously, the Company did not have any other assets or liabilities measured at fair value at September 30, 2019 and December 31, 2018.
Income Taxes	Income Taxes — Accounting for Uncertain Income Tax Positions. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25 Definition of Settlement,
Earnings per Share	Earnings per Share The effects of dilutive instruments have been presented for the year-to-date net income as of September 30, 2019. Other periods presented do not reflect the dilutive shares, as the effects would be anti-dilutive due to the fact that losses are being reflected for those periods. Please refer to the below table for additional details: For the three months For the nine months 2019 2018 2019 2018 Net income (loss) available to common stockholders $ 961,042 $ (4,131,714 ) $ 11,144,342 $ (10,356,876 ) Adjustments for diluted earnings: Preferred Stock Dividend (43,639 ) (169,494 ) Interest expense on convertible notes 105,385 - 348,493 - Amortization of discount on notes payable 528,464 - 707,286 - Diluted net income (loss) available to common stockholders $ 1,594,891 $ (4,175,353 ) $ 12,200,121 $ (10,526,370 ) Income (Loss) per share: Basic $ 0.02 $ (0.08 ) $ 0.19 $ (0.21 ) Diluted $ 0.03 $ (0.08 ) $ 0.20 $ (0.21 ) Weighted average shares outstanding: Basic 59,307,404 51,098,575 58,023,685 49,675,624 Diluted 62,532,510 51,098,575 62,050,032 49,675,624
Share-Based Payments	Share-Based Payments
Cost of Sales	Cost of Sales
Operating Expenses	Operating Expenses
Shipping and Handling Costs	Shipping and Handling Costs
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. In June 2016, the FASB issued ASU No. 2016-13 & updated in Nov 2018 ASU 2018-19, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. ASU 2016-13 is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2019. Early adoption is permitted after fiscal years beginning December 15, 2018. The Company is currently evaluating the potential impact of adopting this guidance on our financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820. The ASU is effective for the Registrants for fiscal years beginning after December 15, 2019, and interim periods therein. Early adoption is permitted. The Company is currently assessing the impact of this standard on our consolidated financial statements. All new accounting pronouncements issued but not yet effective are not expected to have a material impact on our results of operations, cash flows or financial position with the exception of the updated previously disclosed above, there have been no new accounting pronouncements not yet effective that have significance to our consolidated financial statements.
Liquidity	Liquidity In addition to cash flow from operations, our primary sources of working capital have been private placements of our securities and our credit facilities with CD Financial, LLC (“CD Financial”), an affiliate of a principal shareholder of the Company, as well as Charmnew Limited and Grieg International Limited. Charmnew Limited is an existing shareholder of record affiliated with Li Ka Shing, one of our principal shareholders. Grieg International Limited is an existing shareholder of record affiliated with Chau Hoi Shuen Solina, one of our principal shareholders. If our sales volumes do not meet our projections, expenses exceed our expectations, our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Schedule of revenue & accounts receivable with customers	For the nine months ended September 30, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 13.9 % 17.6 % B* 12.9 % 7.9 % All other 73.2 % 74.5 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States. Revenues from all other customers were mainly derived in the United States. At September 30, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 32.4 % 39.1 % B* 11.5 % 5.5 % All other 56.1 % 55.4 % Total 100.0 % 100.0 % * Receivables from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States.
Schedule of exchange rates	As of and for the nine months ended September 30, 2019 and September 30, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: September 30, September 30, Exchange rate on balance sheet dates USD : CNY exchange rate 7.15 6.87 Average exchange rate for the period 7.12 6.85 USD : CNY exchange rate
Schedule of anti-dilutive shares	The effects of dilutive instruments have been presented for the year-to-date net income as of September 30, 2019. Other periods presented do not reflect the dilutive shares, as the effects would be anti-dilutive due to the fact that losses are being reflected for those periods. Please refer to the below table for additional details: For the three months For the nine months 2019 2018 2019 2018 Net income (loss) available to common stockholders $ 961,042 $ (4,131,714 ) $ 11,144,342 $ (10,356,876 ) Adjustments for diluted earnings: Preferred Stock Dividend (43,639 ) (169,494 ) Interest expense on convertible notes 105,385 - 348,493 - Amortization of discount on notes payable 528,464 - 707,286 - Diluted net income (loss) available to common stockholders $ 1,594,891 $ (4,175,353 ) $ 12,200,121 $ (10,526,370 ) Income (Loss) per share: Basic $ 0.02 $ (0.08 ) $ 0.19 $ (0.21 ) Diluted $ 0.03 $ (0.08 ) $ 0.20 $ (0.21 ) Weighted average shares outstanding: Basic 59,307,404 51,098,575 58,023,685 49,675,624 Diluted 62,532,510 51,098,575 62,050,032 49,675,624

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Schedule of net sales by reporting segment	Information about the Company’s net sales by geographical location for the nine months ended September 30, 2019 and 2018 are as follows: For the nine months ended September 30, September 30, 2019 2018 North America $ 42,607,433 $ 27,911,538 Europe 7,635,845 7,097,942 Asia 629,028 2,740,175 Other 159,120 173,964 Net sales $ 51,031,426 $ 37,923,619

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories consist of the following at: September 30, December 31, 2019 2018 Finished goods $ 6,761,898 $ 8,739,877 Raw Materials 2,399,872 2,817,476 Less: Inventory allowance for excess & obsolete products (374,795 ) (74,652 ) Inventories $ 8,786,975 $ 11,482,701

NOTE RECEIVABLE (Tables)

NOTE RECEIVABLE (Tables)	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Schedule of note receivable	Note receivable consists of the following at: September 30, December 31, 2019 2018 Note Receivable-current $ 1,149,791 $ - Note Receivable-non-current 10,348,115 - Total Note Receivable $ 11,497,906 $ -

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of future annual minimum cash payments required under operating lease	Future annual minimum cash payments required under this operating type lease as of September 30, 2019 are as follows: Future Minimum Lease Payments 2019 $ 38,103 2020 128,259 Total Minimum Lease Payments $ 166,362 Less: Amount representing interest (7,031 ) Present value of lease liabilities $ 159,331 Less Current Portion 146,584 Long-Term Portion 12,747

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment consist of the following at: September 30, December 31, 2019 2018 Furniture and equipment $ 505,570 $ 451,576 Less: accumulated depreciation (376,684 ) (329,722 ) Total $ 128,886 $ 121,854

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued expenses	Accounts payable and accrued expenses consist of the following at: September 30, December 31, 2019 2018 Accounts payable $ 5,119,452 $ 5,825,446 Accrued expenses 5,689,151 9,019,765 Total $ 10,808,603 $ 14,845,211

OTHER LIABILITIES (Tables)

OTHER LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2019
Accrued Liabilities and Other Liabilities [Abstract]
Schedule of other liabilities	Other current liabilities consist of the following at: September 30, December 31, 2019 2018 Other Liabilities-State Beverage Container Deposit $ 117,445 $ 19,933 Total $ 117,445 $ 19,933

NOTES PAYABLE - RELATED PARTY (

NOTES PAYABLE - RELATED PARTY (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of notes payable - related parties	Line of credit convertible note payable - related parties consists of the following as of: September 30, December 31, 2019 2018 Note Payable – line of credit In July 2010, the Company entered into a line of credit note payable with a related party and major shareholder which carries interest of five percent per annum paid quarterly. The Company can borrow up to $9,500,000. The Company has pledged all its assets as security for the line of credit. The note matures in January 2020, at which time the principal amount is due. During April 2015, the Company issued $4,000,000 of convertible series D preferred series in exchange for cancellation of $4,000,000 of this line, reducing the amount to $4,500,000. During March 2018, the Company issued $1,000,000 of common stock in exchange for cancellation of $1,000,000 of this line, reducing the amount to $3,500,000. In December 2018, the Company amended and restated the note payable into a line of credit loan agreement continuing to carry a five percent per annum interest but payable semi-annually. The Company can now borrow up to $5.0 million. As a result, of this substantial modification which was treated as a debt extinguishment, a new liability was established and a loss of $377,048 on the extinguishment of debt was recognized. The note had a maturity date of December 2020. In January 2019, the Company increased the borrowed amount by $1,500,000. In September 16, 2019, the principal value of the note was converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. The principal balance of $5.0 million and the accrued but unpaid interest in the amount of $52,778 were converted into common shares. Consequently, a total of $5,052,778 were converted at the conversion price of $3.39 based on the on the average of the closing price for the shares during the ten (10) business days prior to the last advance date, less a discount of 10%, in accordance with the promissory note. As a result of the conversion of the promissory note, the company recognized the remaining un-amortized balance of the discount of $108,454, as interest expense. Long-term portion-Net of Discount $ - $ 3,500,000 September 30, December 31, 2019 2018 Convertible Note Payable In December 2018, the Company entered into a line of credit note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $3.0 million. This note had an unamortized discount of $205,837 and $324,371 as of September 16, 2019 and as of December 31, 2018, respectively. The unamortized discount of $205,837 was recognized as interest expense upon conversion. The note matured in December 2020. In September 16, 2019, the principal value of the note of $3.0 million and the accrued but unpaid interest in the amount of $108,333 were converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. A total of 3,108,333 were converted at the conversion price of $3.04 which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%, resulting in the issuance of 1,022,568 shares. - 2,675,629 In December 2018, the Company entered into a line of credit convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $2.0 million. This note had an unamortized discount of $137,225 and $216,248 as of September 36, 2019 and as of December 31, 2018, respectively. The unamortized discount of $137,225 was recognized as interest expense upon conversion. The note matured in December 2020. In September 16, 2019, the principal value of the note of $2.0 million and the accrued but unpaid interest in the amount of $72,222 were converted into common shares as per promissory note which stated that in the event of financing greater than $25.0 million, there would be an automatic conversion of these balances. A total of 2,072,222 were converted at the conversion price of $3.04 which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%, resulting in the issuance of 681,712 shares. - 1,783,752 Long-term portion-Net of Discount $ - $ 4,459,381

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
Schedule of black - scholes option-pricing model valuation assumption	The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black - Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: Nine months ended September 30, 2019 2018 Expected volatility 58.62%-121.32% 91.19-113.03% Expected term 4.02-5.00 Years 4.7 – 5.06 Years Risk-free interest rate 1.79% - 2.72% 2.56% - 2.86% Forfeiture Rate 0.00% 0.00%
Schedule of outstanding stock options	A summary of the status of the Company’s outstanding stock options as of September 30, 2019 and changes during the period ending on that date is as follows: Weighted Aggregate Intrinsic Average Shares Exercise Value Remaining (000’s) Price (000’s) Term (Yrs) Options Balance at December 31, 2018 4,840 $ 3.04 $ 5,338 5.05 Granted 1,675 $ 3.87 Exercised (900 ) $ 0.97 Forfeiture and cancelled (286 ) $ 2.59 Balance at September 30, 2019 5,329 $ 3.66 $ 2,758 6.10 Exercisable at September 30, 2019 2,305 $ 2.76
Schedule of employee stock options outstanding	The following table summarizes information about employee stock options outstanding at September 30, 2019: Outstanding Options Vested Options Number Number Outstanding Exercisable at Weighted Weighted at Weighted Weighted September 30, Average Average September 30, Average Average Range of 2019 Remaining Exercise 2019 Exercise Remaining Exercise Price (000’s) Term Price (000’s) Price Term $0.20 - $0.53 359 3.45 $ 0.27 359 $ 0.27 3.45 $0.65 - $1.80 342 1.60 $ 1.05 342 $ 1.05 1.60 $1.83 - $2.84 554 0.85 $ 2.06 555 $ 2.07 2.85 $3.20 - $6.20 4,074 7.16 $ 4.39 1,049 4.52 5.23 $7.20 - $22.00 0 0 $ 0 0 $ 0 0 Outstanding options 5,329 6.10 $ 3.66 2,305 $ 2.76 3.84
Summary of restricted stock awards	A summary of the Company’s restricted stock activity for the nine months ended September 30, 2019 and 2018 is presented in the following table: For the Nine Months ended September 30, 2019 September 30, 2018 Weighted Weighted Average Average (000’s) Grant Date (000’s) Grant Date Shares Fair Value Shares Fair Value Unvested at beginning of period 38,889 $ 3.64 72,222 $ — Granted — — — — Vested 8,333 3.64 (25,000 ) — Unvested at end of period 30,556 $ 3.64 47,222 $ 3.64

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)		9 Months Ended		12 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
10% or Greater Revenue [Member]
Concentration Risk [Line Items]
Total		100.00%	100.00%
10% or Greater Revenue [Member] | Customer A [Member]
Concentration Risk [Line Items]
Total	[1]	13.90%	17.60%
10% or Greater Revenue [Member] | Customer B [Member]
Concentration Risk [Line Items]
Total	[1]	12.90%	7.90%
10% or Greater Revenue [Member] | All Other [Member]
Concentration Risk [Line Items]
Total		73.20%	74.50%
10% or Accounts Receivable [Member]
Concentration Risk [Line Items]
Total		100.00%		100.00%
10% or Accounts Receivable [Member] | Customer A [Member]
Concentration Risk [Line Items]
Total	[1]	32.40%		39.10%
10% or Accounts Receivable [Member] | All Other [Member]
Concentration Risk [Line Items]
Total		56.10%		55.40%
10% or Accounts Receivable [Member] | Customer B [Member]
Concentration Risk [Line Items]
Total	[1]	11.50%		5.50%
[1]	Receivables from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in the United States.

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Accounting Policies [Abstract]
Exchange rate on balance sheet dates	7.15	6.87
Average exchange rate for the period	7.12	6.85

BASIS OF PRESENTATION AND SUM_6

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)		3 Months Ended				9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Accounting Policies [Abstract]
Net income (loss) available to common stockholders		$ 961,042	$ (4,175,353)			$ 11,144,342	$ (10,526,370)
Adjustments for diluted earnings:
Preferred stock dividend			(43,639)	$ (43,164)	$ (82,691)		(169,494)
Interest expense on convertible notes		105,385				348,493
Amortization of discount on notes payable		(528,463)				(707,285)
Diluted net income (loss) available to common stockholders		$ 1,594,891	$ (4,175,353)			$ 12,200,121	$ (10,526,370)
Income (Loss) per share:
Basic (in dollars per share)		$ 0.02	$ (0.08)			$ 0.19	$ (0.21)
Diluted (in dollars per share)		$ 0.03	$ (0.08)			$ 0.20	$ (0.21)
Weighted average shares outstanding:
Basic (in shares)		59,307,404	51,098,575			58,023,685	49,675,624
Diluted (in shares)	[1]	62,532,510	51,098,575			62,050,032	49,675,624
[1]	Please refer to Earnings Per Share section for further details

BASIS OF PRESENTATION AND SUM_7

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Amount excess of FDIC limit	$ 20,300,000		$ 20,300,000
Allowance for doubtful accounts	245,682		245,682		$ 183,000
Inventory reserve	$ 374,795		374,795		74,652
Advertising expense			5,400,000	$ 13,100,000
Research and development expense			$ 246,000	313,000
Number of shares available	1,898,195		1,898,195
Freight expense			$ 4,500,000	4,100,000
Accumulated deficit	$ (62,236,350)		(62,236,350)		$ (73,380,691)	[1]
Net (loss) available to common stockholders	$ 961,042	$ (4,175,353)	11,144,342	(10,526,370)
Net cash used in operating activities			$ (966,464)	$ (9,004,864)
Maximum [Member]
Useful life			7 years
Minimum [Member]
Useful life			3 years
[1]	Derived from Audited Financial Statements

REVENUE (Details)

REVENUE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Net sales	$ 20,423,847	$ 16,565,316	$ 51,031,426	$ 37,923,619
North America [Member]
Net sales			42,607,433	27,911,538
Europe [Member]
Net sales			7,635,845	7,097,942
Asia [Member]
Net sales			629,028	2,740,175
Other [Member]
Net sales			$ 159,120	$ 173,964

REVENUE (Details Narrative)

REVENUE (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues	$ 20,423,847	$ 16,565,316	$ 51,031,426	$ 37,923,619
License Agreement [Member]
Royalty fees			6,900,000
Revenues			$ 263,273

INVENTORIES (Details)

INVENTORIES (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 6,761,898	$ 8,739,877
Raw Materials	2,399,872	2,817,476
Less: Inventory allowance for excess & obsolete products	(374,795)	(74,652)
Inventories	$ 8,786,975	$ 11,482,701	[1]
[1]	Derived from Audited Financial Statements

PREPAID EXPENSES AND OTHER CU_2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Prepaid expenses and other current assets	$ 4,212,180	$ 2,299,375	[1]
Prepaid Advertising [Member]
Prepaid expenses and other current assets	$ 4,200,000	$ 2,300,000
[1]	Derived from Audited Financial Statements

NOTE RECEIVABLE (Details)

NOTE RECEIVABLE (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Notes to Financial Statements
Note Receivable-current	$ 1,149,791		[1]
Note Receivable-non-current	10,348,115		[1]
Total Note Receivable	$ 11,497,906
[1]	Derived from Audited Financial Statements

NOTE RECEIVABLE (Details Narrat

NOTE RECEIVABLE (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Notes to Financial Statements
Note Receivable description			Scheduled principal payments plus accrued interest are due annually on March 31 of each year starting in 2020. The Note is recorded at amortized cost basis and accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million.
Weighted average interest rate	3.21%		3.21%
Interest income			$ 288,070
Loss on Investment repayment-China	$ (1,888)		$ 12,050,921

LEASES (Details)

LEASES (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018	[1]
Leases [Abstract]
2019	$ 38,103
2020	128,259
Total Minimum Lease Payments	166,362
Less: Amount representing interest	(7,031)
Present value of lease liabilities	159,331
Less Current Portion	146,584
Long-Term Portion	$ 12,747
[1]	Derived from Audited Financial Statements

LEASE (Details Narrative)

LEASE (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2019	Jan. 02, 2019	Dec. 31, 2018	[1]
Leases [Abstract]
Right to use assets	$ 153,257	$ 259,358
Operating lease liability	159,331
Short-term operating lease liability	146,584
Long term operating lease liability	$ 12,747
Lease description	The monthly rent amounts to $12,452 per month until October 2019 and then increases to $12,826 per month until the termination of the lease in October 2020.
Lease term	13 months
Discount rate	5.00%
[1]	Derived from Audited Financial Statements

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (376,684)	$ (329,722)
Total	128,886	121,854	[1]
Furniture and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 505,570	$ 451,576
[1]	Derived from Audited Financial Statements

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 48,289	$ 34,644

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accounts payable	$ 5,119,452	$ 5,825,446
Accrued expenses	5,689,151	9,019,765
Total	$ 10,808,603	$ 14,845,211	[1]
[1]	Derived from Audited Financial Statements

OTHER LIABILITIES (Details)

OTHER LIABILITIES (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Accrued Liabilities and Other Liabilities [Abstract]
Other Liabilities-State Beverage Container Deposit	$ 117,445	$ 19,933	[1]
Total	$ 117,445	$ 19,933
[1]	Derived from Audited Financial Statements

NOTES PAYABLE - RELATED PARTIES

NOTES PAYABLE - RELATED PARTIES (Details) - USD ($)	Sep. 16, 2019	Jan. 31, 2019	Dec. 31, 2018		Mar. 31, 2018	Apr. 30, 2015	Jul. 31, 2010	Sep. 30, 2019
Long-term portion-Net of Discount			$ 3,500,000	[1]
5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | CD Financial, LLC [Member]
Long-term portion-Net of Discount			3,500,000
Maximum borrowing capacity			$ 5,000,000				$ 9,500,000
Debt maturity date			Dec. 31, 2020				Jan. 2, 2020
Loss on debt extinguishment			$ (377,048)
Conversion of common stock	5,052,778
Unamortized discount	$ 108,454
Conversion price	$ 3.39
Discount rate	10.00%
Principal balance	$ 5,000,000
Accured interest	52,778
5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | CD Financial, LLC [Member] | 5% Series D Preferred Stock [Member]
Number of shares issued upon debt cancellation					1,000,000	4,000,000
Debt cancelled amount					$ 1,000,000	$ 4,000,000
Increased in borrowed amount		$ 1,500,000
5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | CD Financial, LLC [Member] | Minimum [Member]
Principal balance	$ 25,000,000
[1]	Derived from Audited Financial Statements

NOTES PAYABLE - RELATED PARTI_2

NOTES PAYABLE - RELATED PARTIES (Details 1) - USD ($)	Sep. 16, 2019	Sep. 30, 2019	Dec. 31, 2018
Long-term portion-Net of Discount			$ 4,459,381
5% Convertible Note Payable [Member] | Related Party And Shareholder [Member]
Long-term portion-Net of Discount			2,675,629
Maximum borrowing capacity			3,000,000
Unamortized discount	$ 205,837		324,371
Debt maturity date	Dec. 31, 2020
Conversion of common stock	3,108,333
Conversion price	$ 3.04
Discount rate	10.00%
Principal balance	$ 3,000,000
Accured interest	$ 108,333
Debt issuance of shares	1,022,568
5% Convertible Note Payable [Member] | Related Party And Shareholder [Member] | Minimum [Member]
Principal balance	$ 25,000,000
5% Line of Credit Convertible Note Payable [Member] | Related Party And Shareholder [Member]
Long-term portion-Net of Discount			1,783,752
Maximum borrowing capacity			2,000,000
Unamortized discount	$ 137,225		$ 216,248
Debt maturity date	Dec. 31, 2020
Conversion of common stock	2,072,222
Conversion price	$ 3.04
Discount rate	10.00%
Principal balance	$ 2,000,000
Accured interest	$ 72,222
Debt issuance of shares	681,712
5% Line of Credit Convertible Note Payable [Member] | Related Party And Shareholder [Member] | Minimum [Member]
Principal balance	$ 25,000,000

PREFERRED STOCK - RELATED PAR_2

PREFERRED STOCK - RELATED PARTY (Details Narrative) - USD ($)	Apr. 16, 2015	Aug. 26, 2013	Mar. 31, 2018	Oct. 31, 2017	Apr. 30, 2015	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Series D Preferred Stock [Member]
Number of preferred stock converted			4,000					4,000
Conversion of preferred stock into common stock			4,651,163
CD Financial, LLC [Member] | Carl DeSantis [Member] | 5% Series D Preferred Stock [Member] | Amendment Loan and Security Agreement [Member]
Number of shares issued upon debt conversion	4,000
Conversion price (in dollars per share)	$ 0.86
Liquidation preference (in dollars per share)	$ 1,000
Accrued dividend	$ 139,535
Preferred stock redemption date	Jan. 2, 2021
Share price (in dollars per share)	$ 0.89
Dividend payable (in dollars per share)	$ 0.03
Preferred stock redemption price, percent	104.00%
Conversion of preferred stock into common stock			4,651,163
CD Financial, LLC [Member] | 5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | Amendment Loan and Security Agreement [Member]
Line of credit reduction borrowing capacity	$ 4,000,000
CD Financial, LLC [Member] | 5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | Securities Purchase Agreement [Member]
Original debt conversion amount		$ 1,650,000
CDS Ventures of South Florida, LLC [Member] | Carl DeSantis [Member] | 6% Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of shares issued upon accrued dividend				383	180
Value of shares issued upon accrued dividend				$ 383,000	$ 180,000
Accrued dividend				$ 383,000	$ 180,000	$ 255,903
Preferred stock redemption date							Dec. 31, 2018
Number of preferred stock converted						256
Conversion of preferred stock into common stock						5,806,022
CDS Ventures of South Florida, LLC [Member] | Short Term Loan [Member] | Carl DeSantis [Member] | Securities Purchase Agreement [Member]
Original debt conversion amount		$ 550,000
CDS Ventures of South Florida, LLC & CD Financial, LLC [Member] | Carl DeSantis [Member] | 6% Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of shares issued upon debt conversion		2,200
Conversion price (in dollars per share)		$ 0.52
Liquidation preference (in dollars per share)		$ 1,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - CD Financial, LLC [Member] - Office [Member] - Carl DeSantis [Member]	9 Months Ended
	Sep. 30, 2019USD ($)
Lease expiration	2020-10
Monthly expense	$ 12,452

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	Sep. 16, 2019	Jul. 31, 2018	Mar. 31, 2018	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2018
Fair value of shares issued upon services rendered				$ 279,600
Proceeds from Options exercised					$ 224,083	$ 179,704
Number of options exercised					900,000
Net proceeds from sale of common stock					$ 26,955,437
2006 & 2015 Stock Incentive Plan [Member]
Number of option shares granted					690,179	712,190
Value of option shares granted						$ 180,308
Proceeds from Options exercised					$ 224,083
Number of options exercised					245,584
Series D Preferred Stock [Member]
Number of preferred stock converted			4,000				4,000
Conversion of preferred stock into common stock			4,651,163
Public Placement [Member]
Number of shares issued upon services	7,986,110
Net proceeds from sale of common stock	$ 26,955,437
Gross proceeds	28,749,996
commissions & fees	1,585,000
Expenses related to the capital raise	209,559
Common Stock [Member]
Number of shares issued upon services				60,000
Fair value of shares issued upon services rendered				$ 60
Principal value	25,000,000
Restricted Common Stock [Member] | Statewide [Member]
Fair value of shares issued upon services rendered		$ 279,600
Stock price (in dollars per share)		$ 4.66
Stock issued for settlement of legal matter		60,000
Notes Payable [Member]
Principal value	$ 10,000,000
Notes Payable [Member] | Initial Public Offering [Member]
Number of shares issued upon services	3,196,460
Principal value	$ 27,063,779

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Forfeiture Rate	0.00%	0.00%
Maximum [Member]
Expected volatility	121.32%	91.19%
Expected term	5 years	5 years 22 days
Risk-free interest rate	2.72%	2.86%
Minimum [Member]
Expected volatility	58.62%	113.03%
Expected term	4 years 7 days	4 years 8 months 12 days
Risk-free interest rate	1.79%	2.56%

STOCK-BASED COMPENSATION (Det_2

STOCK-BASED COMPENSATION (Details 1)	9 Months Ended
	Sep. 30, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Balance at beginning | shares	4,840,000
Granted | shares	1,675,000
Exercised | shares	(900,000)
Forfeiture and cancelled | shares	(286,000)
Balance at end | shares	5,329,000
Exercisable at end | shares	2,305,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Balance at beginning | $ / shares	$ 3.04
Granted | $ / shares	3.87
Exercised | $ / shares	0.97
Forfeiture and cancelled | $ / shares	2.59
Balance at end | $ / shares	3.66
Exercisable at end | $ / shares	$ 2.76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Roll Forward]
Balance at beginning | $	$ 5,338,000
Balance at end | $	$ 2,758,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Average Remaining Term [Roll Forward]
Balance at beginning	5 years 18 days
Balance at end	6 years 1 month 6 days

STOCK-BASED COMPENSATION (Det_3

STOCK-BASED COMPENSATION (Details 2)	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Outstanding Options
Number Outstanding at end | shares	5,329,000
Weighted Averaged Remaining Life	6 years 1 month 6 days
Weighted Averaged Exercise Price | $ / shares	$ 3.66
Vested Options
Number Exercisable at end | shares	2,305,000
Weighted Averaged Exercise Price | $ / shares	$ 2.76
Weighted Averaged Remaining Life	3 years 10 months 2 days
$0.20 - $0.53 [Member]
Outstanding Options
Number Outstanding at end | shares	359,000
Weighted Averaged Remaining Life	3 years 5 months 12 days
Weighted Averaged Exercise Price | $ / shares	$ 0.27
Vested Options
Number Exercisable at end | shares	359,000
Weighted Averaged Exercise Price | $ / shares	$ 0.27
Weighted Averaged Remaining Life	3 years 5 months 12 days
$0.65 - $1.80 [Member]
Outstanding Options
Number Outstanding at end | shares	342,000
Weighted Averaged Remaining Life	1 year 7 months 6 days
Weighted Averaged Exercise Price | $ / shares	$ 1.05
Vested Options
Number Exercisable at end | shares	342,000
Weighted Averaged Exercise Price | $ / shares	$ 1.05
Weighted Averaged Remaining Life	1 year 7 months 6 days
$1.83 - $2.84 [Member]
Outstanding Options
Number Outstanding at end | shares	554,000
Weighted Averaged Remaining Life	10 months 6 days
Weighted Averaged Exercise Price | $ / shares	$ 2.06
Vested Options
Number Exercisable at end | shares	555,000
Weighted Averaged Exercise Price | $ / shares	$ 2.07
Weighted Averaged Remaining Life	2 years 10 months 6 days
$3.20 - $6.20 [Member]
Outstanding Options
Number Outstanding at end | shares	4,074,000
Weighted Averaged Remaining Life	7 years 1 month 28 days
Weighted Averaged Exercise Price | $ / shares	$ 4.39
Vested Options
Number Exercisable at end | shares	1,049,000
Weighted Averaged Exercise Price | $ / shares	$ 4.52
Weighted Averaged Remaining Life	5 years 2 months 23 days
$7.20 - $22.00 [Member]
Outstanding Options
Number Outstanding at end | shares	0
Weighted Averaged Remaining Life	0 years
Weighted Averaged Exercise Price | $ / shares	$ 0
Vested Options
Number Exercisable at end | shares	0
Weighted Averaged Exercise Price | $ / shares	$ 0
Weighted Averaged Remaining Life	0 years

STOCK-BASED COMPENSATION (Det_4

STOCK-BASED COMPENSATION (Details 3) - $ / shares	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Number of Shares
Unvested at beginning of period	38,889,000	72,222,000
Restricted stock vested	8,333,000	(25,000,000)
Unvested at end of period	30,556,000	47,222,000
Weighted Average Grant-Date Fair Value per Share
Unvested at beginning of period	$ 3.64
Restricted stock granted
Restricted stock vested	3.64
Unvested at end of period	$ 3.64	$ 3.64

STOCK-BASED COMPENSATION (Det_5

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	Jan. 18, 2007	Apr. 30, 2015	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Feb. 28, 2015	May 31, 2014	Dec. 31, 2013
Number of shares available			1,898,195		1,898,195
Average share price (in dollars per share)			$ 3.87
Unrecognized pre-tax non-cash compensation expense to non-vested option			$ 7,217,396		$ 7,217,396
Period unrecognized pre-tax non-cash compensation expense to non-vested option			3 years
Number of shares vested			2,300,000
Stock Incentive Plan [Member]
Plan expiration term	10 years
Number of shares authorized	2,500,000	5,100,000				4,600,000	4,250,000	3,500,000
Stock Incentive Plan 2015 [Member]
Number of shares authorized		5,000,000
Description of plan		Provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2017
Purchase of common shares				1,710,000
Stock Option Plan 2015 [Member]
Purchase of common shares			1,680,000		5,330,000
Average share price (in dollars per share)					$ 3.66
Fair value of common shares purchased					$ 2,760,000
General And Administrative Expense [Member]
Non-cash compensation expense			$ 3,354,295	$ 3,103,778
Director [Member]
Unrecognized compensation expense			$ 50,709		$ 50,709
Weighted average period of unrecognized compensation expense			5 months 1 day
Maximum [Member]
Vesting period			3 years
Minimum [Member]
Vesting period			2 years

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	Sep. 25, 2019	Sep. 30, 2019
Escrow amount		$ 14,849,999
Share Purchase Agreement [Member] | Nordics distributor [Member]
Escrow amount	$ 14,008,999
Maturity date	Oct. 25, 2019

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Func Food Group OYJ [Member]	Oct. 25, 2019USD ($)
Acquisition ownership percentage	100.00%
Acquisition cost	$ 24,200,000
Cash acquired on acquisition	14,800,000
bond issuances, Net of discount	9,400,000
Bond discount	476,000
Account receivable	$ 4,600,000